Cargando…
Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer
BACKGROUND: Intravesical Bacilli Calmette-Guerin (IVBCG) therapy for non-muscle invasive bladder cancer (NMIBC) has long been in use successfully. Albeit rarely, we still face with its safety concerns more than 25 years on since its approval by US Food and Drug Agency in 1990. Local and systemic inf...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719568/ https://www.ncbi.nlm.nih.gov/pubmed/29212486 http://dx.doi.org/10.1186/s12894-017-0304-5 |